These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 15596278)
1. Association of 20q13.2 copy number changes with the advanced stage of ovarian cancer-tissue microarray analysis. Dimova I; Yosifova A; Zaharieva B; Raitcheva S; Doganov N; Toncheva D Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):81-5. PubMed ID: 15596278 [TBL] [Abstract][Full Text] [Related]
2. Association of CyclinD1 copy number changes with histological type in ovarian tumors. Dimova I; Zaharieva B; Raicheva S; Milev I; Dimitrov R; Doganov N; Aleksandrov M; Todorov T; Toncheva D Acta Oncol; 2004; 43(7):675-9. PubMed ID: 15545188 [TBL] [Abstract][Full Text] [Related]
3. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas. Sonoda G; Palazzo J; du Manoir S; Godwin AK; Feder M; Yakushiji M; Testa JR Genes Chromosomes Cancer; 1997 Dec; 20(4):320-8. PubMed ID: 9408747 [TBL] [Abstract][Full Text] [Related]
4. Prognostic relevance of 20q13 gains in sporadic colorectal cancers: a FISH analysis. Aust DE; Muders M; Köhler A; Schmidt M; Diebold J; Müller C; Löhrs U; Waldman FM; Baretton GB Scand J Gastroenterol; 2004 Aug; 39(8):766-72. PubMed ID: 15513363 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target. Fejzo MS; Dering J; Ginther C; Anderson L; Ramos L; Walsh C; Karlan B; Slamon DJ Genes Chromosomes Cancer; 2008 Oct; 47(10):873-83. PubMed ID: 18615678 [TBL] [Abstract][Full Text] [Related]
6. 20q13 and cyclin D1 in ovarian carcinomas. Analysis by fluorescence in situ hybridization. Diebold J; Mösinger K; Peiro G; Pannekamp U; Kaltz C; Baretton GB; Meier W; Löhrs U J Pathol; 2000 Apr; 190(5):564-71. PubMed ID: 10727982 [TBL] [Abstract][Full Text] [Related]
7. Correlations between c-myc gene copy-number and clinicopathological parameters of ovarian tumours. Dimova I; Raitcheva S; Dimitrov R; Doganov N; Toncheva D Eur J Cancer; 2006 Mar; 42(5):674-9. PubMed ID: 16458500 [TBL] [Abstract][Full Text] [Related]
8. Differences in 20q13.2 copy number between colorectal cancers with and without liver metastasis. Hidaka S; Yasutake T; Takeshita H; Kondo M; Tsuji T; Nanashima A; Sawai T; Yamaguchi H; Nakagoe T; Ayabe H; Tagawa Y Clin Cancer Res; 2000 Jul; 6(7):2712-7. PubMed ID: 10914715 [TBL] [Abstract][Full Text] [Related]
9. CAS (cellular apoptosis susceptibility) gene expression in ovarian carcinoma: Correlation with 20q13.2 copy number and cyclin D1, p53, and Rb protein expression. Peiró G; Diebold J; Löhrs U Am J Clin Pathol; 2002 Dec; 118(6):922-9. PubMed ID: 12472286 [TBL] [Abstract][Full Text] [Related]
10. Genetic analysis of early- versus late-stage ovarian tumors. Shridhar V; Lee J; Pandita A; Iturria S; Avula R; Staub J; Morrissey M; Calhoun E; Sen A; Kalli K; Keeney G; Roche P; Cliby W; Lu K; Schmandt R; Mills GB; Bast RC; James CD; Couch FJ; Hartmann LC; Lillie J; Smith DI Cancer Res; 2001 Aug; 61(15):5895-904. PubMed ID: 11479231 [TBL] [Abstract][Full Text] [Related]
11. Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma. Jazaeri AA; Lu K; Schmandt R; Harris CP; Rao PH; Sotiriou C; Chandramouli GV; Gershenson DM; Liu ET Mol Carcinog; 2003 Feb; 36(2):53-9. PubMed ID: 12557260 [TBL] [Abstract][Full Text] [Related]
12. An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer. Suzuki S; Moore DH; Ginzinger DG; Godfrey TE; Barclay J; Powell B; Pinkel D; Zaloudek C; Lu K; Mills G; Berchuck A; Gray JW Cancer Res; 2000 Oct; 60(19):5382-5. PubMed ID: 11034075 [TBL] [Abstract][Full Text] [Related]
13. 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells. Savelieva E; Belair CD; Newton MA; DeVries S; Gray JW; Waldman F; Reznikoff CA Oncogene; 1997 Feb; 14(5):551-60. PubMed ID: 9053853 [TBL] [Abstract][Full Text] [Related]
14. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma. Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer. Schlomm T; Kirstein P; Iwers L; Daniel B; Steuber T; Walz J; Chun FH; Haese A; Kollermann J; Graefen M; Huland H; Sauter G; Simon R; Erbersdobler A Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6579-84. PubMed ID: 18006757 [TBL] [Abstract][Full Text] [Related]
16. High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer. Simon R; Richter J; Wagner U; Fijan A; Bruderer J; Schmid U; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Anabitarte M; Hering F; Hardmeier T; Schönenberger A; Flury R; Jäger P; Fehr JL; Schraml P; Moch H; Mihatsch MJ; Gasser T; Sauter G Cancer Res; 2001 Jun; 61(11):4514-9. PubMed ID: 11389083 [TBL] [Abstract][Full Text] [Related]
17. Trisomy 8 in stage I and stage III ovarian cancer detected by fluorescence in situ hybridization. Mark HF; Afify AM; Werness BA; Das S; Mark S; Samy M Exp Mol Pathol; 1999 Apr; 66(1):76-81. PubMed ID: 10331967 [TBL] [Abstract][Full Text] [Related]
18. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus. Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552 [TBL] [Abstract][Full Text] [Related]
19. Detection of 20q13 gain by dual-color FISH in breast cancers. Kobayashi Y; Esato K; Noshima S; Oga A; Sasaki K Anticancer Res; 2000; 20(1B):531-5. PubMed ID: 10769720 [TBL] [Abstract][Full Text] [Related]
20. Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications. Tanner MM; Tirkkonen M; Kallioniemi A; Holli K; Collins C; Kowbel D; Gray JW; Kallioniemi OP; Isola J Clin Cancer Res; 1995 Dec; 1(12):1455-61. PubMed ID: 9815944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]